DiaMedica Inc.
TSX VENTURE : DMA
OTCQB : DMCAF

DiaMedica Inc.

December 01, 2015 07:00 ET

DiaMedica to Present at the 2015 GCFF Shenzhen China Conference

MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 1, 2015) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced that the Company will be presenting at the 2015 Global Chinese Financial Forum ("GCFF") Shenzhen Conference taking place December 3 - 4, 2015 at the Futian Shangri-La Hotel in Shenzhen, China.

Rick Pauls, President and CEO, is scheduled to present on Thursday, December 3, 2015 at 14:55pm. Management will also be available for one-on-one meetings as they meet with the Chinese investment community and pharmaceutical companies throughout the week.

About the 2015 GCFF Shenzhen China Conference

The GCFF Shenzhen China Conference, sponsored by NAI Interactive Ltd, is held December 3 - 4, 2015 at the Futian Shangri-La Hotel in Shenzhen, China with corporate presentations in both English and Chinese for qualified Chinese investors and pharmaceutical firms. The event will feature tracks devoted to Life Sciences, Technology, Mining and Oil & Gas. The Conference will include corporate presentations and Q&A sessions, investor one-on-one meetings and networking opportunities.

About DiaMedica

DiaMedica is a publicly traded clinical stage biopharmaceutical company focused on developing novel protein therapeutics for vascular diseases, including stroke, and metabolic and kidney dysfunction. DiaMedica's common shares are listed on the TSX-V Exchange under the trading symbol "DMA" and on the OTCQB under the trading symbol "DMCAF".

FORWARD-LOOKING STATEMENTS

The statements made in this press release that are not historical facts contain forward-looking information that involves risk and uncertainties. All statements, other than statements of historical facts, which address DiaMedica's expectations should be considered forward-looking statements. Such statements are based on management's exercise of business judgment as well as assumptions made by and information currently available to management. When used in this document, the words "may", "will", "anticipate", "believe", "estimate", "expect", "intend" and words of similar import, are intended to identify any forward-looking statements. You should not place undue reliance on these forward-looking statements. These statements reflect a current view of future events and are subject to certain risks and uncertainties as contained in DiaMedica's filings with Canadian securities regulatory authorities. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results could differ materially from those anticipated in these forward-looking statements. DiaMedica undertakes no obligation, and does not intend, to update, revise or otherwise publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of any unanticipated events, unless required by law. Although management believes that expectations are based on reasonable assumptions, no assurance can be given that these expectations will materialize.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the contents of this press release.

Contact Information